After graduating in Biology, André did his PhD in Molecular Biomedicine in Prof. Michael Hoch's lab at the University of Bonn, Germany. He joined Prof. Andreas Prokop's group at the University of Manchester as postdoctoral researcher and was awarded a fellowship of the German Research Foundation in 2015. In 2021, André joined Prof. Alan Dickson's lab at the Manchester Institute of Biotechnology on a collaboration project with Pharmaron Biologics Ltd, UK. In 2023, André joined the Faculty of Science and Engineering/Biological Sciences at the University of Hull where he is a Lecturer in Cell Biology. His research group explores host cell – virus interactions in the context of the manufacture of cell and gene therapies.
André is also Honorary Research Fellow at the University of Manchester and member of cohort 5a of the BioIndustry Association’s Manufacturing Advisory Committee Leadership Programme (BIA MAC LeaP).
Dr Voelzmann’s group is interested in optimising the manufacturability of viral vector-based cell and gene therapies. The current research focus lies on understanding producer cell-virus interactions in the context of recombinant Adenoassociated Virus assembly, ssDNA loading, viral trafficking, and viral egress. The aim is to leverage these insights to help optimise gene therapy production on an industrial scale.